CERO · Cero Therapeutics Holdings, Inc.
$0.01
+0.00 (+0.00%)
At close · Jul 30
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year from the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 15, 2026
Market Cap
$451,124
Shares
45.11M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-01-07 | CERo Therapeutics Shareholder Update | Shareholder meeting |
| 2025-10-22 | CERo Therapeutics to Participate in Stem Cell Therapy Panel at the Maxim Growth Summit 2025 | Event |
| 2025-03-12 | CERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14 | Event |
Source: https://www.cero.bio/investors